Skip to content

Biohaven BHVN Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.23B+19.0%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$1.06M+401%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$24.04M+310%
uniQure logo
uniQureQURE
$30.15M+455%
Roivant Sciences logo
Roivant SciencesROIV
$40.92M+24.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$18.62M+12.1%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.23B-48.1%
Enterprise value$2.23B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsMiscellaneousNoncurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's other non-current assets?
Biohaven (BHVN) reported other non-current assets of $2.31M in Q1 2026.
How has Biohaven's other non-current assets changed year-over-year?
Biohaven's other non-current assets decreased by 27.3% year-over-year, from $3.18M to $2.31M.
What is the long-term trend for Biohaven's other non-current assets?
Over 4 years (2021 to 2025), Biohaven's other non-current assets has grown at a -8.0% compound annual growth rate (CAGR), from $3.22M to $2.31M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.